FOOD AND DRUG ADMINISTRATION

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

CELLULAR, TISSUE AND GENE THERAPIES ADVISORY COMMITTEE

MEETING #45

April 10, 2008

**[BIBLIOGRAPHY]{.underline}**

1.  Blum B and N Benvenisty. (2007). Clonal analysis of human embryonic
    stem cell differentiation into teratomas. Stem Cells 25:1924-1930.

2.  Brederlau A, AS Correia, SV Anisimov, M Elmi, G Paul, L Roybon, A
    Morizane, F Bergquist, I Riebe, U Nannmark, M Carta, E Hanse, J
    Takahashi, Y Sasai, K Funa, P Brundin, PS Eriksson and JY Li.
    (2006). Transplantation of human embryonic stem cell-derived cells
    to a rat model of Parkinson\'s disease: effect of in vitro
    differentiation on graft survival and teratoma formation. Stem Cells
    24:1433-1440.

3.  Caspi O, I Huber, I Kehat, M Habib, G Arbel, A Gepstein, L
    Yankelson, D Aronson, R Beyar and L Gepstein. (2007).
    Transplantation of human embryonic stem cell-derived cardiomyocytes
    improves myocardial performance in infarcted rat hearts. J Am Coll
    Cardiol 50:1884-1893.

4.  Drukker M, H Katchman, G Katz, S Even-Tov Friedman, E Shezen, E
    Hornstein, O Mandelboim, Y Reisner and N Benvenisty. (2006). Human
    embryonic stem cells and their differentiated derivatives are less
    susceptible to immune rejection than adult cells. Stem Cells
    24:221-229.

5.  Erdo F, C Buhrle, J Blunk, M Hoehn, Y Xia, B Fleischmann, M Focking,
    E Kustermann, E Kolossov, J Hescheler, KA Hossmann and T Trapp.
    (2003). Host-dependent tumorigenesis of embryonic stem cell
    transplantation in experimental stroke. J Cereb Blood Flow Metab
    23:780-785.

6.  Lawrenz B, H Schiller, E Willbold, M Ruediger, A Muhs and S Esser.
    (2004). Highly sensitive biosafety model for stem-cell-derived
    grafts. Cytotherapy 6:212-222.

7.  Leor J, S Gerecht-Nir, S Cohen, L Miller, R Holbova, A Ziskind, M
    Shachar, MS Feinberg, E Guetta and J Itskovitz-Eldor. (2007). Human
    embryonic stem cell transplantation to repair the infarcted
    myocardium. Heart.

8.  Oottamasathien S, Y Wang, K Williams, OE Franco, ML Wills, JC
    Thomas, K Saba, AR Sharif-Afshar, JH Makari, NA Bhowmick, RT
    DeMarco, S Hipkens, M Magnuson, JW Brock, 3rd, SW Hayward, JCt Pope
    and RJ Matusik. (2007). Directed differentiation of embryonic stem
    cells into bladder tissue. Dev Biol 304:556-566.

9.  Phillips BW, H Hentze, WL Rust, QP Chen, H Chipperfield, EK Tan, S
    Abraham, A Sadasivam, PL Soong, ST Wang, R Lim, W Sun, A Colman and
    NR Dunn. (2007). Directed differentiation of human embryonic stem
    cells into the pancreatic endocrine lineage. Stem Cells Dev
    16:561-578.

10. 

Przyborski SA. (2005). Differentiation of human embryonic stem cells
after transplantation in immune-deficient mice. Stem Cells 23:1242-1250.

11. 
12. 

Shih CC, SJ Forman, P Chu and M Slovak. (2007). Human embryonic stem
cells are prone to generate primitive, undifferentiated tumors in
engrafted human fetal tissues in severe combined immunodeficient mice.
Stem Cells Dev 16:893-902.Tian X, PS Woll, JK Morris, JL Linehan and DS
Kaufman. (2006). Hematopoietic engraftment of human embryonic stem
cell-derived cells is regulated by recipient innate immunity. Stem Cells
24:1370-1380.